Showing results (2311-2320 of 2,345) with videos related to
Sort By:
Pageof 235
American Heart Journal|November 27, 2019
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HFAdam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.Frontiers in Reproductive Health|June 29, 2023
Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in KenyaNelly R Mugo, Victor Mudhune, Renee Heffron, et al.The Lancet. HIV|May 1, 2024
Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trialIan Frank, Shuying S Li, Nicole Grunenberg, et al.NPJ Vaccines|April 16, 2021
Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humansKelly E Seaton, Aaron Deal, Xue Han, et al.Journal of Cognitive Neuroscience|January 10, 2025
Beyond Increasing Sample Sizes: Optimizing Effect Sizes in Neuroimaging Research on Individual DifferencesColin G DeYoung, Kirsten Hilger, Jamie L Hanson, et al.Journal of the American College of Cardiology|April 5, 2022
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.Journal of the American College of Cardiology|April 5, 2022
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesPaul A Heidenreich, Biykem Bozkurt, David Aguilar, et al.NPJ Precision Oncology|February 13, 2026
Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumabEric Y Stutheit-Zhao, Yongqi Zhong, Collin A Melton, et al.Bioorganic & Medicinal Chemistry Letters|August 6, 2008
Discovery of a potent and selective aurora kinase inhibitorJohan D Oslob, Michael J Romanowski, Darin A Allen, et al.Pageof 235